Skip to content

Legal status · United Kingdom

Is Tirzepatide with BPC-157 legal in the United Kingdom?

Written by Reviewed Sep 2026

Not approvedMetabolicStudies in people cited: 1

Direct answer

No. Tirzepatide with BPC-157 is not an approved medicine in the United Kingdom. Its legal category is "Not licensed". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.

People given it
0
Found nothing
0

Legal category

Not licensed

Tirzepatide is licensed. BPC-157 is an unlicensed medicine, and supplying it for human use is illegal.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Tirzepatide with BPC-157 in the United Kingdom at a glance

Legal categoryNot licensed
NoteTirzepatide is licensed. BPC-157 is an unlicensed medicine, and supplying it for human use is illegal.
MHRA approval statusNot approved by MHRA
Studies in people1 of 4 sources on the profile
ReviewedSep 2026

The legal category and note come from the Tirzepatide with BPC-157 profile. We checked them against Medicines and Healthcare products Regulatory Agency (MHRA) listings on the reviewed date.

What this means

  • 01

    No product containing Tirzepatide with BPC-157 is approved by MHRA for any use in the United Kingdom. So nothing on sale is allowed for use in people.

  • 02

    "Research use only" is a label sellers put on. It is not a legal category that allows use in people, and it does not get a product out of medicines law.

  • 03

    Importing it, supplying it or promoting it for use in people can fall under medicines law in the United Kingdom. This page is general information, not legal advice.

What Tirzepatide with BPC-157 is

The same pairing idea as the semaglutide version. One side has a bigger weight loss effect. The other side is just as empty. Tirzepatide 15 mg cut weight by 20.9% on average at 72 weeks. BPC-157 has five studies in people with under 110 people in all, and none gave it the way it is used here. Nobody has studied the pair. US pharmacies are not allowed to make BPC-157.

Tirzepatide works so well that the muscle question gets sharper than with semaglutide. In the big SURMOUNT-1 study, 57% of people on 15 mg lost 20% or more of their body weight over 72 weeks.

How it works: Tirzepatide copies two gut hormones, GIP and GLP-1. It turns down appetite and slows how fast the stomach empties.

Approval history: Tirzepatide is approved. BPC-157 is not approved. FDA staff reviewed it in July 2026 and found no adequate human data, and pharmacies are not allowed to mix it. The combination has never been reviewed.

How MHRA treats this kind of product

Licenses medicines for sale in the UK. A compound without a licence to be sold (a marketing authorisation) is an unlicensed medicine. The law only lets it reach people through a prescriber, under the specials scheme (unlicensed medicines made for one patient's needs). It cannot be sold as a research product.

The legal category above is how The Longevity Archive reads Medicines and Healthcare products Regulatory Agency listings for Tirzepatide with BPC-157 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check MHRA directly

Tirzepatide with BPC-157 in sport and the military

Whether Tirzepatide with BPC-157 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United Kingdom. Before you compete or get tested, look up Tirzepatide with BPC-157 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Tirzepatide with BPC-157 in other countries

Frequently asked questions

Is Tirzepatide with BPC-157 legal in the United Kingdom?

No. Tirzepatide with BPC-157 is not an approved medicine in the United Kingdom. Its legal category is "Not licensed". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile. Note: Tirzepatide is licensed. BPC-157 is an unlicensed medicine, and supplying it for human use is illegal.

Can I buy Tirzepatide with BPC-157 in the United Kingdom?

There is no approved product to buy. In the United Kingdom, Tirzepatide with BPC-157 has the legal category "Not licensed". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything. Note: Tirzepatide is licensed. BPC-157 is an unlicensed medicine, and supplying it for human use is illegal.

Is Tirzepatide with BPC-157 MHRA approved?

No. In the United Kingdom, Tirzepatide with BPC-157 has the legal category "Not licensed". That is not a MHRA approval to sell it. For comparison, its US FDA status is: Tirzepatide is approved. BPC-157 is not approved. FDA staff reviewed it in July 2026 and found no adequate human data, and pharmacies are not allowed to mix it. The combination has never been reviewed.. On the evidence, 1 completed human trial is cited on its profile.

Related compounds in the United Kingdom

Full research profile

How Tirzepatide with BPC-157 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Tirzepatide with BPC-157 profile

This page is general information about the legal status of Tirzepatide with BPC-157 in the United Kingdom, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Medicines and Healthcare products Regulatory Agency or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.